Sign in
4

Changes in Ownership

Cytosorbents Corp Filed Acc 0001144204-15-039317

Director sold 13,205 shares at an average $7.33 ($96,781)

  • Director acquired 13,205 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Kraus Al · Director

Table I: Non-derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2015-06-24 Exercise or conversion : show line 1 in the form +3,205 $5.50 $17,628 58,746 D
2015-06-24 Sale : show line 2 in the form −3,205 $7.00 $22,435 55,746 D
2015-06-25 Exercise or conversion : show line 3 in the form +10,000 $0.88 $8,750 65,746 D
2015-06-25 Sale : show line 4 in the form −10,000 $7.43 $74,346 55,746 D
Open-market sales · 13,205 sh · avg $7.33 · $96,781

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2015-06-24 Exercise or conversion : show line 5 in the form Stock Option −3,205 0 D
2015-06-15 Exercise or conversion : show line 6 in the form Stock Option −10,000 166,773 D
Loading xslF345X03/v414210_4.xml…